These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Tribo-Charging Behaviour of Inhalable Mannitol Blends with Salbutamol Sulphate. Zellnitz S; Pinto JT; Brunsteiner M; Schroettner H; Khinast J; Paudel A Pharm Res; 2019 Apr; 36(6):80. PubMed ID: 30968221 [TBL] [Abstract][Full Text] [Related]
9. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate. Mönckedieck M; Kamplade J; Fakner P; Urbanetz NA; Walzel P; Steckel H; Scherließ R Int J Pharm; 2017 May; 524(1-2):351-363. PubMed ID: 28347847 [TBL] [Abstract][Full Text] [Related]
10. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery. Dhumal RS; Biradar SV; Paradkar AR; York P Int J Pharm; 2009 Feb; 368(1-2):129-37. PubMed ID: 18996462 [TBL] [Abstract][Full Text] [Related]
11. Preparation of functional composite particles of salbutamol sulfate using a 4-fluid nozzle spray-drying technique. Chen R; Okamoto H; Danjo K Chem Pharm Bull (Tokyo); 2008 Mar; 56(3):254-9. PubMed ID: 18310932 [TBL] [Abstract][Full Text] [Related]
12. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery. Nolan LM; Tajber L; McDonald BF; Barham AS; Corrigan OI; Healy AM Eur J Pharm Sci; 2009 Jul; 37(5):593-602. PubMed ID: 19463948 [TBL] [Abstract][Full Text] [Related]
13. Production of fast-dissolving low-density powders for improved lung deposition by spray drying of a nanosuspension. Šimková K; Joost B; Imanidis G Eur J Pharm Biopharm; 2020 Jan; 146():19-31. PubMed ID: 31734282 [TBL] [Abstract][Full Text] [Related]
14. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers. Corrigan DO; Corrigan OI; Healy AM Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654 [TBL] [Abstract][Full Text] [Related]
15. Interest of cyclodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide. Dufour G; Bigazzi W; Wong N; Boschini F; de Tullio P; Piel G; Cataldo D; Evrard B Int J Pharm; 2015 Nov; 495(2):869-78. PubMed ID: 26410753 [TBL] [Abstract][Full Text] [Related]
16. Effect of crystallisation conditions and feedstock morphology on the aerosolization performance of micronised salbutamol sulphate. Shariare MH; de Matas M; York P Int J Pharm; 2011 Aug; 415(1-2):62-72. PubMed ID: 21683128 [TBL] [Abstract][Full Text] [Related]
17. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate. Thi TH; Danède F; Descamps M; Flament MP Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120 [TBL] [Abstract][Full Text] [Related]
18. Drug transport across pulmonary epithelial cell monolayers: effects of particle size, apical liquid volume, and deposition technique. Bur M; Huwer H; Muys L; Lehr CM J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):119-27. PubMed ID: 20073555 [TBL] [Abstract][Full Text] [Related]
19. Physico-Chemical Properties, Aerosolization and Dissolution of Co-Spray Dried Azithromycin Particles with L-Leucine for Inhalation. Mangal S; Nie H; Xu R; Guo R; Cavallaro A; Zemlyanov D; Zhou QT Pharm Res; 2018 Jan; 35(2):28. PubMed ID: 29374368 [TBL] [Abstract][Full Text] [Related]
20. Solid lipid budesonide microparticles for controlled release inhalation therapy. Mezzena M; Scalia S; Young PM; Traini D AAPS J; 2009 Dec; 11(4):771-8. PubMed ID: 19908147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]